ইতালী - ইতালীয় - AIFA (Agenzia Italiana del Farmaco)

abbvie s.r.l. - levobupivacaina - levobupivacaina

ইতালী - ইতালীয় - AIFA (Agenzia Italiana del Farmaco)

abbvie s.r.l. - tossina botulinica - tossina botulinica

ইউরোপীয় ইউনিয়ন - ইতালীয় - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - dalbavancin hydrochloride - soft tissue infections; skin diseases, bacterial - antibatterici per uso sistemico, - trattamento delle infezioni batteriche acute della pelle e della struttura cutanea (absssi) negli adulti.

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - carmellosum natricum - collirio - carmellosum natricum 10 mg, natrii chloridum, natrii lactas, kalii chloridum, calcii chloridum dihydricum, aqua purificata q.s. ad solutionem pro 1 ml. - lacrime artificiali - synthetika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - ritonavirum - sirup - ritonavirum 600 mg, aromatica, saccharinum natricum, color.: e 110, excipiens ad solutionem pro 7.5 ml corresp. ethanolum 43.2 % v/v. - hiv-infektionen - synthetika human

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - palivizumabum - injektionspräparat - preparazione cryodesiccata: palivizumabum 73 mg, glycinum, histidinum, mannitolum, per il vetro. rilascio: acqua iniectabilia, per il vetro, corrisp. soluzione reconstituta 0,5 ml con palivizumabum 50 mg. - rsv-prophylaxe - biotechnologika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - palivizumabum - injektionspräparat - preparazione cryodesiccata: palivizumabum 122 mg, glycinum, histidinum, mannitolum, per il vetro. rilascio: acqua iniectabilia, per il vetro, corrisp. soluzione reconstituta 1 ml con palivizumabum 100 mg. - rsv-prophylaxe - biotechnologika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - paricalcitolum - capsule - paricalcitolum 1 µg antiox.: e 321, excipiens per la capsula. - behandlung des sekundären hyperparathyreoidismus ckd 3, 4 und 5 stufe - synthetika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - paricalcitolum - capsule - paricalcitolum 2 µg, antiox.: e 321, excipiens per la capsula. - behandlung des sekundären hyperparathyreoidismus ckd 3, 4 und 5 stufe - synthetika

সুইজারল্যান্ড - ইতালীয় - Swissmedic (Swiss Agency for Therapeutic Products)

abbvie ag - linaclotidum - capsule - linaclotidum 0.29 mg, cellulosum microcristallinum, hypromellosum, calcii chloridum dihydricum, leucinum, kapselhülle: gelatina, e 172 (rubrum), e 171, e 172 (flavum), macrogolum 3350, drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, e 171, e 172 (nigrum), pro capsula. - trattamento sintomatico di moderata a grave reizkolon sindrome di stipsi negli adulti - synthetika